Examination of changes in TGF-beta1 and KL-6 expression over time in patients with chronic hepatitis C by AT-II receptor blocker therapy

J Gastroenterol. 2005 Aug;40(8):855-6. doi: 10.1007/s00535-004-1643-z.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Antigens / biosynthesis*
  • Antigens, Neoplasm
  • Female
  • Glycoproteins / biosynthesis*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Mucin-1
  • Mucins / biosynthesis*
  • Transforming Growth Factor beta / biosynthesis*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Antigens
  • Antigens, Neoplasm
  • Glycoproteins
  • MUC1 protein, human
  • Mucin-1
  • Mucins
  • Transforming Growth Factor beta